Track INBX and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
INBX - Inhibrx Biosciences, Inc. (INBX) has a earnings per share of -$2.15, up 23.2% over the past year.
Latest EPS (Actual)
-$2.15
Beat Rate
50.0%
Most Recent
Miss
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | -$1.20 | -$2.15 | Miss | -79.17% |
| Mar 2026 | -$1.63 | -$2.11 | Miss | -29.45% |
| Nov 2025 | -$1.72 | -$2.28 | Miss | -32.56% |
| Aug 2025 | -$2.60 | -$1.85 | Beat | +28.85% |
| May 2025 | -$3.12 | -$2.80 | Beat | +10.26% |
| Mar 2025 | -$1.44 | -$3.09 | Miss | -114.58% |
| Nov 2024 | -$3.70 | -$2.84 | Beat | +23.24% |
| Aug 2024 | -$1.52 | $125.48 | Beat | +8355.26% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.